Find more items about these cancer types:

Breast (ER Positive)

Treating Early Breast Cancer

(00:03:38) Elsevier Global Medical News, 2010 Nov 23, H Splete

The 10-year follow-up data from the Arimidex, Tamoxifen Alone, or in Combination (ATAC) trial continue to show that the adjuvant anastrozole significantly reduces the rate of breast cancer recurrence and secondary primary breast cancer in comparison with tamoxifen in postmenopausal, hormone receptor–positive patients, Dr. Aman Buzdar explains.

Copyright © 2010 International Medical News Group
Subscribe Now »

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration